Stifel Maintains Hold on Inspire Medical Systems, Lowers Price Target to $170
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Jonathan Block maintains a Hold rating on Inspire Medical Systems (NYSE:INSP) and lowers the price target from $210 to $170.
June 24, 2024 | 12:57 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Stifel analyst Jonathan Block maintains a Hold rating on Inspire Medical Systems (NYSE:INSP) and lowers the price target from $210 to $170.
The lowered price target from $210 to $170 by Stifel suggests a less optimistic outlook for Inspire Medical Systems, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100